Ganot Capital
6
26M
4
0.50
3
0.33
1
- Stages of investment
- Areas of investment
Summary
The venture was found in North America in United States. The main department of described VC is located in the Hollywood.
Among the most popular portfolio startups of the fund, we may highlight Kyma Medical Technologies, Azura Ophthalmics. The fund has no exact preference in some founders of portfolio startups. Besides, a startup requires to be at the age of 4-5 years to receive the investment from the fund. We can highlight the next thriving fund investment areas, such as Information Technology, Biotechnology. For fund there is no match between the location of its establishment and the land of its numerous investments - Israel.
The standard case for the fund is to invest in rounds with 2 partakers. The meaningful sponsors for the fund in investment in the same round are TPG Biotech, OrbiMed, Medical Research Commercialisation Fund (MRCF).
The fund is constantly included in less than 2 investment rounds annually. The top activity for fund was in 2017. Despite it in 2019 the fund had an activity. The top amount of exits for fund were in 2015. The common things for fund are deals in the range of 10 - 50 millions dollars.
The overall number of key employees were 2.
Investments analytics
Analytics
- Total investments
- 6
- Lead investments
- 3
- Exits
- 1
- Rounds per year
- 0.50
- Follow on index
- 0.33
- Investments by industry
- Health Care (6)
- Medical (5)
- Medical Device (3)
- Biotechnology (2)
- Information Technology (1)
- Investments by region
-
- United States (2)
- Israel (4)
- Peak activity year
- 2019
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 16
- Group Appearance index
- 0.50
- Avg. company exit year
- 7
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Azura Ophthalmics | 10 Oct 2017 | Biotechnology, Health Care, Medical | Early Stage Venture | 16M | Israel, Tel Aviv District, Tel Aviv-Yafo |
Similar funds
By same location
By same geo focus
By doing lead investments
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.